Data Collection for Patients With Low Grade Ovarian or Peritoneal Tumors

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
AgeNot listed
SponsorM.D. Anderson Cancer Center

About this trial

This study collects information to maintain a database on patients with low-grade ovarian or peritoneal tumors. Collecting information about the type of cancer and treatment, as well as details about follow-up care, may help researchers learn and better understand these tumor types and help develop better treatments for them.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Ovarian tumor of low malignant potential

Low-grade serous carcinoma of the ovary

Primary peritoneal tumor of low malignant potential

Low-grade serous carcinoma of the peritoneum

Disqualifiers

None

Trial population

Patients with a low-grade tumor of Mullerian origin who sought treatment or a second opinion at MD Anderson Cancer Center (MDACC) at any point in the course of their disease and treatment (beginning in January 1950), and patients currently being treated at MDACC or seeking treatment or a second opinion in the future

Trial design

Design model

Cohort

Time perspective

Other

Treatments tested in this trial

  • Biospecimen Collection

    Procedure/Surgery

    Patients' residual tissue samples are collected

  • Electronic Health Record Review

    Other intervention

    Medical records are reviewed

Treatment groups

2,000 Participants
are divided into 1 treatment group
Group A: Observational (electronic health record review)2 interventions

Trial outcomes

Primary outcomes

1

Prospective and retrospective data collection on disease characterization, treatment, and outcomes

Time frame
Up to 28 years
2

Organization of clinical information

Will be done in order to support multifaceted queries of patient characteristics, treatment, and disease outcome data and to facilitate correlation of these characteristics with patient outcome.

Time frame
Up to 28 years
3

Creation of a single data repository to integrate clinical information and research findings

Time frame
Up to 28 years

Secondary outcomes

1

Collection and storage of human tumor samples for the establishment of a tumor bank

Time frame
Up to 28 years

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.